详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

PSM Analysis Results from REFRACT: A Multi-Center Cohort Study Investigating the Treatment Patterns in EGFR-Mutant Unresectable LA- NSCLC

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

单位： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Dept Radiat Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China [2]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China [3]Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Zhejiang, Peoples R China [4]Harbin Med Univ Canc Hosp, Harbin, Heilongjiang, Peoples R China [5]Huazhong Univ Sci & Technol, Tongji Hosp Tongji Med Univ, Wuhan, Hubei, Peoples R China [6]Shanxi Med Univ, Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China [7]Shanxi Med Univ, Affiliated Canc Hosp, Taiyuan, Shanxi, Peoples R China [8]Beijing Chest Hosp, Capital Med Univ, Beijing, Peoples R China [9]Shandong First Med Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China [10]Zhejiang Univ, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Hangzhou Peoples Hosp 1, Dept Oncol,Sch Med, Hangzhou, Zhejiang, Peoples R China [11]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China [12]Cangzhou Cent Hosp, Cangzhou, Peoples R China [13]Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China [14]Fujian Med Univ Canc Hosp, Fuzhou, Fujian, Peoples R China [15]John S Hopkins Med, Biostat & Bioinformat, Baltimore, MD USA [16]Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Clin Res Ctr Canc, Natl Canc Ctr,Canc Hosp, Shenzhen, Guangdong, Peoples R China

出处：

ISSN：

关键词： non-small cell lung cancer locally advanced EGFR mutation

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2019]版：

Q1 RESPIRATORY SYSTEM Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 21.1 最新[2023版] 16.5 最新五年平均 13.357 出版当年[2019版] 10.089 出版当年五年平均 12.46 出版前一年[2018版] 15.609 出版后一年[2020版]

第一作者：

第一作者单位： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Dept Radiat Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [2]Radiation dose effect in locally advanced non-small cell lung cancer [3]Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer [4]Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [5]Treatment-related deaths after concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: A meta-analysis of randomized studies [6]Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies [7]Treatment-related deaths after concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: A meta-analysis of randomized studies [8]A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer [9]Sequential use of EGFR-tyrosine kinase inhibitors based upon EGFR mutation evolution achieves long-term control in a non-small cell lung cancer patient: a case report [10]Detection of EGFR T790M in Asia-Pacific patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Circulating tumour (ct) DNA analysis across 3 platforms